{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:22:50Z","timestamp":1761823370794,"version":"build-2065373602"},"reference-count":107,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.recesp.2010.12.004","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T04:28:21Z","timestamp":1300249701000},"page":"319-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neurolog\u00eda y cardiolog\u00eda: puntos de contacto"],"prefix":"10.1016","volume":"64","author":[{"given":"Larry B.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"El Husseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.recesp.2010.12.004_bib0005","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2174\/138945007781077427","article-title":"Prevention of ischemic stroke: antithrombotic therapy in cardiac embolism","volume":"8","author":"Cervera","year":"2007","journal-title":"Curr Drug Targets."},{"key":"10.1016\/j.recesp.2010.12.004_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke."},{"key":"10.1016\/j.recesp.2010.12.004_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","article-title":"Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators","volume":"35","author":"Hart","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0020","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/01.wnl.0000325059.86313.31","article-title":"Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke","volume":"71","author":"Tayal","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.recesp.2010.12.004_bib0025","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/STROKEAHA.110.582437","article-title":"Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke","volume":"41","author":"Kamel","year":"2010","journal-title":"Stroke."},{"key":"10.1016\/j.recesp.2010.12.004_bib0030","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.107.501825","article-title":"Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation","volume":"39","year":"2008","journal-title":"Stroke."},{"key":"10.1016\/j.recesp.2010.12.004_bib0035","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.recesp.2010.12.004_bib0040","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFA) Study","volume":"18","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0050","doi-asserted-by":"crossref","unstructured":"The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323:1505\u201311.","DOI":"10.1056\/NEJM199011293232201"},{"key":"10.1016\/j.recesp.2010.12.004_bib0055","first-page":"527","article-title":"Final results","volume":"84","year":"1991","journal-title":"Circulation."},{"key":"10.1016\/j.recesp.2010.12.004_bib0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet."},{"key":"10.1016\/j.recesp.2010.12.004_bib0065","doi-asserted-by":"crossref","unstructured":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449\u201357.","DOI":"10.1001\/archinte.1994.00420130036007"},{"key":"10.1016\/j.recesp.2010.12.004_bib0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJM199608223350802","article-title":"An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation","volume":"335","author":"Hylek","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0075","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1001\/archinte.160.18.2781","article-title":"Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland","volume":"160","author":"Heiro","year":"2000","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0080","doi-asserted-by":"crossref","unstructured":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet. 1993;342:1255\u201362.","DOI":"10.1016\/0140-6736(93)92358-Z"},{"key":"10.1016\/j.recesp.2010.12.004_bib0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.recesp.2010.12.004_bib0090","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet."},{"key":"10.1016\/j.recesp.2010.12.004_bib0095","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0100","article-title":"Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study","volume":"159","year":"2010","journal-title":"Am Heart J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0105","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(03)14841-6","article-title":"Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial","volume":"362","author":"Olsson","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.recesp.2010.12.004_bib0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2005.10.044","article-title":"Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study","volume":"47","author":"Meissner","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2009.07.035","article-title":"Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale","volume":"159","author":"Lopes","year":"2010","journal-title":"Am Heart J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.recesp.2010.12.004_bib0130","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1212\/WNL.55.8.1172","article-title":"Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies","volume":"55","author":"Overell","year":"2000","journal-title":"Neurology."},{"key":"10.1016\/j.recesp.2010.12.004_bib0135","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.jacc.2009.04.001","volume":"53","author":"O\u2019Gara","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0140","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1161\/01.CIR.0000020353.63751.2F","article-title":"Patent foramen ovale and recurrent stroke: another paradoxical twist","volume":"105","author":"Halperin","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.recesp.2010.12.004_bib0145","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0002-9149(97)00604-8","article-title":"Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack","volume":"80","author":"Lethen","year":"1997","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0150","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.recesp.2010.12.004_bib0155","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1161\/STROKEAHA.108.521427","article-title":"Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study","volume":"39","author":"Serena","year":"2008","journal-title":"Stroke."},{"key":"10.1016\/j.recesp.2010.12.004_bib0160","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"345","author":"Mas","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0165","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2004.05.044","article-title":"Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke","volume":"44","author":"Windecker","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0733-8619(18)30160-9","article-title":"Coronary artery disease, myocardial infarction, and brain embolism","volume":"11","author":"Hess","year":"1993","journal-title":"Neurol Clin."},{"key":"10.1016\/j.recesp.2010.12.004_bib0175","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ahj.2009.03.020","article-title":"Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era","volume":"157","author":"Osherov","year":"2009","journal-title":"Am Heart J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0180","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1161\/01.CIR.99.18.2371","article-title":"Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb\/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators","volume":"99","author":"Mahaffey","year":"1999","journal-title":"Circulation."},{"key":"10.1016\/j.recesp.2010.12.004_bib0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2796.2004.01433.x","article-title":"Factors associated with development of stroke long-term after myocardial infarction: experiences from the LoWASA trial","volume":"257","author":"Herlitz","year":"2005","journal-title":"J Intern Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0190","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1056\/NEJM198902093200610","article-title":"Left ventricular thrombi and cerebral embolism","volume":"320","author":"Fuster","year":"1989","journal-title":"N Engl J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial","volume":"360","author":"Van Es","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.recesp.2010.12.004_bib0200","doi-asserted-by":"crossref","first-page":"S776","DOI":"10.1378\/chest.08-0685","article-title":"The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Becker","year":"2008","journal-title":"Chest."},{"key":"10.1016\/j.recesp.2010.12.004_bib0205","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S1474-4422(10)70185-X","article-title":"Haemodynamic stroke: clinical features, prognosis, and management","volume":"9","author":"Klijn","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0210","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1161\/STROKEAHA.109.561670","article-title":"Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"40","author":"Pullicino","year":"2009","journal-title":"Stroke."},{"key":"10.1016\/j.recesp.2010.12.004_bib0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000191327.62136.b1","article-title":"Cardiac encephalopathy and congestive heart failure: a hypothesis about the relationship","volume":"66","author":"Caplan","year":"2006","journal-title":"Neurology."},{"key":"10.1016\/j.recesp.2010.12.004_bib0220","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.57.11.1945","article-title":"Cognitive impairment in congestive heart failure?: Embolism vs hypoperfusion","volume":"57","author":"Pullicino","year":"2001","journal-title":"Neurology."},{"key":"10.1016\/j.recesp.2010.12.004_bib0225","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/str.32.11.2462","article-title":"Cerebral blood flow and neurological change in chronic heart failure","volume":"32","author":"Ackerman","year":"2001","journal-title":"Stroke."},{"key":"10.1016\/j.recesp.2010.12.004_bib0230","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1445-5994.2001.00067.x","article-title":"The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning","volume":"31","author":"Almeida","year":"2001","journal-title":"Intern Med J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0235","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/01688639708403754","article-title":"Memory improvement following cardiac transplantation","volume":"19","author":"Roman","year":"1997","journal-title":"J Clin Exp Neuropsychol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0240","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0404.1995.tb07001.x","article-title":"Neuropsychological function in patients with end-stage heart failure before and after cardiac transplantation","volume":"91","author":"Bornstein","year":"1995","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.recesp.2010.12.004_bib0245","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/0735-1097(89)90013-2","article-title":"Cognitive function in patients with symptomatic dilated cardiomyopathy before and after cardiac transplantation","volume":"14","author":"Schall","year":"1989","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.09.002","article-title":"Stroke in heart failure: atrial fibrillation revisited?","volume":"19","author":"Pullicino","year":"2010","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"10.1016\/j.recesp.2010.12.004_bib0255","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ahj.2005.10.018","article-title":"Ischemic stroke after heart failure: a community-based study","volume":"152","author":"Witt","year":"2006","journal-title":"Am Heart J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0260","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.54.2.288","article-title":"Stroke in patients with heart failure and reduced left ventricular ejection fraction","volume":"54","author":"Pullicino","year":"2000","journal-title":"Neurology."},{"key":"10.1016\/j.recesp.2010.12.004_bib0265","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-8703(07)80021-4","article-title":"Low incidence of stroke in ambulatory patients with heart failure: a prospective study","volume":"126","author":"Katz","year":"1993","journal-title":"Am Heart J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cardfail.2005.01.001","article-title":"The year in heart failure: 2004","volume":"11","author":"Massie","year":"2005","journal-title":"J Card Fail."},{"key":"10.1016\/j.recesp.2010.12.004_bib0275","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cardfail.2004.02.006","article-title":"The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics","volume":"10","author":"Massie","year":"2004","journal-title":"J Card Fail."},{"key":"10.1016\/j.recesp.2010.12.004_bib0280","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial","volume":"119","author":"Massie","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.recesp.2010.12.004_bib0285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cardfail.2005.07.007","article-title":"Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design","volume":"12","author":"Pullicino","year":"2006","journal-title":"J Card Fail."},{"key":"10.1016\/j.recesp.2010.12.004_bib0290","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/01.STR.31.11.2628","article-title":"Predictors of cerebrovascular events and death among patients with valvular heart disease: A population-based study","volume":"31","author":"Petty","year":"2000","journal-title":"Stroke."},{"key":"10.1016\/j.recesp.2010.12.004_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199907013410101","article-title":"Prevalence and clinical outcome of mitral-valve prolapse","volume":"341","author":"Freed","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0300","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archneur.1976.00500110045008","article-title":"Cerebral ischemic events associated with prolapsing mitral valve","volume":"33","author":"Barnett","year":"1976","journal-title":"Arch Neurol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0305","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1212\/WNL.45.6.1083","article-title":"Mitral valve prolapse and the risk of stroke after initial cerebral ischemia","volume":"45","author":"Orencia","year":"1995","journal-title":"Neurology."},{"key":"10.1016\/j.recesp.2010.12.004_bib0310","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0002-9343(79)90452-2","article-title":"Calcification of the mitral annulus: etiology, clinical associations, complications and therapy","volume":"66","author":"Fulkerson","year":"1979","journal-title":"Am J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/hrt.32.1.26","article-title":"Systemic embolism in mitral valve disease","volume":"32","author":"Coulshed","year":"1970","journal-title":"Br Heart J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0320","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/jnnp.37.4.378","article-title":"Cerebral embolism and mitral stenosis: survival with and without anticoagulants","volume":"37","author":"Adams","year":"1974","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.recesp.2010.12.004_bib0325","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bmj.1.5392.1209","article-title":"Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease","volume":"1","author":"Szekely","year":"1964","journal-title":"Br Med J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0330","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/01.CIR.72.5.1059","article-title":"Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial","volume":"72","author":"Mok","year":"1985","journal-title":"Circulation."},{"key":"10.1016\/j.recesp.2010.12.004_bib0335","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N Engl J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0340","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.STR.0000229894.28591.3f","article-title":"Neurological outcome of septic cardioembolic stroke after infective endocarditis","volume":"37","author":"Ruttmann","year":"2006","journal-title":"Stroke."},{"key":"10.1016\/j.recesp.2010.12.004_bib0345","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMcps0801308","article-title":"Clinical problem-solving. Taken out of context","volume":"359","author":"Thomas","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0350","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00415-009-5364-3","article-title":"Impact of stroke on therapeutic decision making in infective endocarditis","volume":"257","author":"Derex","year":"2010","journal-title":"J Neurol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0355","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/588663","article-title":"Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers","volume":"47","author":"Snygg-Martin","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.recesp.2010.12.004_bib0360","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/oxfordjournals.eurheartj.a060195","article-title":"Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis","volume":"13","author":"Rohmann","year":"1992","journal-title":"Eur Heart J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0365","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1212\/01.WNL.0000094359.47929.E4","article-title":"Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis","volume":"61","author":"Anderson","year":"2003","journal-title":"Neurology."},{"key":"10.1016\/j.recesp.2010.12.004_bib0370","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1161\/01.CIR.0000153812.64956.EF","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.recesp.2010.12.004_bib0375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ehj.2003.11.008","article-title":"Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology","volume":"25","author":"Horstkotte","year":"2004","journal-title":"Eur Heart J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0380","first-page":"703","article-title":"Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis","volume":"10","author":"Piper","year":"2001","journal-title":"J Heart Valve Dis."},{"key":"10.1016\/j.recesp.2010.12.004_bib0385","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s00415-004-0517-x","article-title":"Timing the valve replacement in infective endocarditis involving the brain","volume":"251","author":"Angstwurm","year":"2004","journal-title":"J Neurol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0390","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2003.11.033","article-title":"Characteristics of cerebrovascular accidents after percutaneous coronary interventions","volume":"43","author":"Dukkipati","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0395","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.CIR.0000020678.16325.E0","article-title":"Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications","volume":"106","author":"Fuchs","year":"2002","journal-title":"Circulation."},{"issue":"18 Suppl 3","key":"10.1016\/j.recesp.2010.12.004_bib0400","first-page":"S818","article-title":"Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care","volume":"122","author":"Jauch","year":"2010","journal-title":"Circulation."},{"key":"10.1016\/j.recesp.2010.12.004_bib0405","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jacc.2007.09.068","article-title":"The safety and efficacy of thrombolysis for strokes after cardiac catheterization","volume":"51","author":"Khatri","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0410","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0003-4975(99)01569-6","article-title":"Stroke after coronary artery operation: incidence, correlates, outcome, and cost","volume":"69","author":"Puskas","year":"2000","journal-title":"Ann Thorac Surg."},{"key":"10.1016\/j.recesp.2010.12.004_bib0415","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0003-4975(01)03030-2","article-title":"Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation","volume":"72","author":"Moazami","year":"2001","journal-title":"Ann Thorac Surg."},{"key":"10.1016\/j.recesp.2010.12.004_bib0420","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0003-4975(03)00455-7","article-title":"Thrombolytic therapy for delayed, in-hospital stroke after cardiac surgery","volume":"76","author":"Fukuda","year":"2003","journal-title":"Ann Thorac Surg."},{"key":"10.1016\/j.recesp.2010.12.004_bib0425","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archneur.58.4.598","article-title":"Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline?","volume":"58","author":"Selnes","year":"2001","journal-title":"Arch Neurol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0430","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0003-4975(03)00021-3","article-title":"Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls","volume":"75","author":"Selnes","year":"2003","journal-title":"Ann Thorac Surg."},{"key":"10.1016\/j.recesp.2010.12.004_bib0435","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1212\/01.wnl.0000175220.78475.99","article-title":"Is there cognitive decline 1 year after CABG? Comparison with surgical and nonsurgical controls","volume":"65","author":"McKhann","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.recesp.2010.12.004_bib0440","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jama.287.11.1405","article-title":"Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial","volume":"287","author":"Van Dijk","year":"2002","journal-title":"JAMA."},{"key":"10.1016\/j.recesp.2010.12.004_bib0445","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ccc.2006.06.002","article-title":"Neurocardiogenic injury in neurovascular disorders","volume":"22","author":"Kopelnik","year":"2006","journal-title":"Crit Care Clin."},{"key":"10.1016\/j.recesp.2010.12.004_bib0450","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ncl.2004.03.001","article-title":"Cardiac function tests in neuromuscular diseases","volume":"22","author":"Bhakta","year":"2004","journal-title":"Neurol Clin."},{"key":"10.1016\/j.recesp.2010.12.004_bib0455","first-page":"e23","article-title":"Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy","volume":"25","author":"Breton","year":"2009","journal-title":"Can J Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0460","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","article-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1","volume":"358","author":"Groh","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0465","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000099055","article-title":"Association of electrocardiographic abnormalities with cardiac findings and neuromuscular disorders in left ventricular hypertrabeculation\/non-compaction","volume":"107","author":"Stollberger","year":"2007","journal-title":"Cardiology."},{"key":"10.1016\/j.recesp.2010.12.004_bib0470","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.recesp.2010.12.004_bib0475","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0195-668X(02)00387-1","article-title":"Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings","volume":"24","author":"Holmgren","year":"2003","journal-title":"Eur Heart J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0480","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/08830738020170101701","article-title":"Cardiomyopathy associated with neurologic disorders and mitochondrial phenotype","volume":"17","author":"Marin-Garcia","year":"2002","journal-title":"J Child Neurol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0485","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.410010104","article-title":"Lumping or splitting? \u201cOphthalmoplegia-plus\u201d or Kearns-Sayre syndrome?","volume":"1","author":"Berenberg","year":"1977","journal-title":"Ann Neurol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0490","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2169\/internalmedicine.43.204","article-title":"Subclinical Becker's muscular dystrophy presenting with severe heart failure","volume":"43","author":"Yokota","year":"2004","journal-title":"Intern Med."},{"key":"10.1016\/j.recesp.2010.12.004_bib0495","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/hrt.2007.138461","article-title":"Duchenne muscular dystrophy: how bad is the heart?","volume":"94","author":"McNally","year":"2008","journal-title":"Heart."},{"key":"10.1016\/j.recesp.2010.12.004_bib0500","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-10-33","article-title":"Myocardial inflammation in Duchenne Muscular Dystrophy as a precipitating factor for heart failure: a prospective study","volume":"10","author":"Mavrogeni","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0505","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1532-429X-10-50","article-title":"Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach","volume":"10","author":"Yilmaz","year":"2008","journal-title":"J Cardiovasc Magn Reson."},{"key":"10.1016\/j.recesp.2010.12.004_bib0510","doi-asserted-by":"crossref","unstructured":"Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord. 2003;13:166\u201372.","DOI":"10.1016\/S0960-8966(02)00213-4"},{"key":"10.1016\/j.recesp.2010.12.004_bib0515","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.recesp.2010.12.004_bib0520","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","article-title":"Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years\u2019 follow-up","volume":"154","author":"Duboc","year":"2007","journal-title":"Am Heart J."},{"key":"10.1016\/j.recesp.2010.12.004_bib0525","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.STR.0000064322.47667.49","article-title":"Clinical relevance of atrial fibrillation\/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study","volume":"34","author":"Boriani","year":"2003","journal-title":"Stroke."},{"key":"10.1016\/j.recesp.2010.12.004_bib0530","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0960-8966(00)00206-6","article-title":"A mutation in the X-linked Emery-Dreifuss muscular dystrophy gene in a patient affected with conduction cardiomyopathy","volume":"11","author":"Vohanka","year":"2001","journal-title":"Neuromuscul Disord."},{"key":"10.1016\/j.recesp.2010.12.004_bib0535","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1053-2498(03)00204-3","article-title":"Cardiac transplantation in twins with autosomal dominant Emery-Dreifuss muscular dystrophy","volume":"23","author":"Kichuk Chrisant","year":"2004","journal-title":"J Heart Lung Transplant."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300893211001941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300893211001941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:55:55Z","timestamp":1759539355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300893211001941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0300893211001941"],"URL":"https:\/\/doi.org\/10.1016\/j.recesp.2010.12.004","relation":{},"ISSN":["0300-8932"],"issn-type":[{"type":"print","value":"0300-8932"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurolog\u00eda y cardiolog\u00eda: puntos de contacto","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2010.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}